Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets.
Chesney, C M
Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets. [electronic resource] - Biochemical and biophysical research communications Apr 1987 - 359-66 p. digital
Publication Type: Journal Article
0006-291X
10.1016/s0006-291x(87)80518-1 doi
Alprazolam--metabolism
Binding, Competitive
Blood Platelets--drug effects
Diazepam--metabolism
Humans
In Vitro Techniques
Kinetics
Platelet Activating Factor--metabolism
Platelet Aggregation--drug effects
Triazolam--metabolism
Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets. [electronic resource] - Biochemical and biophysical research communications Apr 1987 - 359-66 p. digital
Publication Type: Journal Article
0006-291X
10.1016/s0006-291x(87)80518-1 doi
Alprazolam--metabolism
Binding, Competitive
Blood Platelets--drug effects
Diazepam--metabolism
Humans
In Vitro Techniques
Kinetics
Platelet Activating Factor--metabolism
Platelet Aggregation--drug effects
Triazolam--metabolism